LUER-LOK
Report
- Report Number
- 9610847-2026-00100
- Event Type
- Malfunction
- Date Received
- March 13, 2026
- Date of Event
- January 14, 2026
- Report Date
- May 4, 2026
- Manufacturer
- BD INFUSION THERAPY SYSTEMS INC. S.A. DE C.V.
- Product Code
- FMF
- UDI-DI
- 00382903056170
- PMA / PMN Number
- K110771
- Product Problem
- Yes
- Report Source
- Manufacturer report
- Reporter Location
- TX, US
- Reporter Occupation
- OTHER HEALTH CARE PROFESSIONAL
- Health Professional
- Yes
Narratives
H.3. IF A DEVICE EVALUATION AND/OR DEVICE HISTORY REVIEW IS COMPLETED, A SUPPLEMENTAL REPORT WILL BE FILED.
IT WAS REPORTED BY CUSTOMER THAT BD 20ML SYRINGE LOT 5181420, IR SPECTRUM DEMONSTRATED A 79.2 MATCH TO SILICONE LUBRICANT AND, WHEN COMPARED TO THE BROADER FTIR LIBRARY, A 93.7 MATCH TO SILASTIC Q7 4550, A PEROXIDE CURED MEDICAL GRADE SILICONE ELASTOMER CONSISTENT WITH STOPPER CONSTRUCTION. RCC RECEIVED A COMPLAINT VIA EMAIL. DMR # (B)(4) PO #: (B)(4) DEFECT MATERIAL DESCRIPTION: SYRINGE TRAY, 20ML BD 10PK (REF. 305617) LOT NUMBER: 5181420 ITEM CODE: 305617 DEFECTIVE QUANTITIES: 1 DEFECT DESCRIPTION: BD 20ML SYRINGE LOT 5181420, IR SPECTRUM DEMONSTRATED A 79.2 MATCH TO SILICONE LUBRICANT AND, WHEN COMPARED TO THE BROADER FTIR LIBRARY, A 93.7 MATCH TO SILASTIC Q7 4550, A PEROXIDE CURED MEDICAL GRADE SILICONE ELASTOMER CONSISTENT WITH STOPPER CONSTRUCTION. NO UNITS ARE AVAILABLE TO BE RETURNED. OBSERVED DATE: (B)(6) 2026 OBSERVED DURING WHICH PROCESS STAGE: ILP IR/ DMI NUMBER IF LAUNCHED: DEV-04209 SAMPLE AVAILABILITY FOR SUPPLIER TO INVESTIGATE: NO IS DEFECTIVE EVIDENCE (I.E. PICTURES; TEST RESULTS ETC.) AVAILABLE? YES, IS PATIENT IMPACTED? NO IF DEFECT HAS BEEN REPORTED TO THIRD PARTY? NO IF THE DEFECT REPORT FROM QUVA CUSTOMER? NO IS THERE A TREND OBSERVED? NO".
Devices
| Seq | Brand | Generic | Product Code | Manufacturer | Model | Lot | UDI-DI |
|---|---|---|---|---|---|---|---|
| 484555 | LUER-LOK | SYRINGE | FMF | BD INFUSION THERAPY SYSTEMS INC. S.A. DE C.V. | 5181420 | 00382903056170 |
Patients
| Seq | Age | Sex | Outcome | Treatment |
|---|---|---|---|---|
| 1 | NA | Unknown |